Intergen Company

n its role as a leading supplier, Intergen has supported the development of many of the leading break through biopharmaceuticals on the market today. Intergen products are found in a wide variety of innovative biotechnology drugs and diagnostics in cancer therapeutics, hematology, immunology, cardiovascular and infectious disease management. The company's products are contained in tens of millions of assays produced each year by leading clinical diagnostic manufacturers worldwide.

Intergen's commitment to the development of life sciences begins with our innovative products used in the general study of molecular biology and cancer. Intergen Discovery Products™, a division of the company, is committed to bringing innovative products to academic and industrial researchers around the world. Using the company's expertise in large-scale biological manufacturing to GMP standards, Intergen is well positioned to help our customers advance their products from research and development to manufacturing.

Intergen is headquartered in Purchase, New York and maintains manufacturing and research development facilities in Gaithersburg, Maryland; Milford, Massachusetts and Toronto, Canada. Intergen Europe is headquartered in Oxford, England and the company maintains strategic marketing partners in Japan.